{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:07:43Z","timestamp":1783386463291,"version":"3.54.6"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Thymic epithelial tumors originate from the epithelial cells of the thymus and are typically diagnosed during the 5th and 6th decades of life. The incidence is consistent between men and women, averaging 1.7 cases per year. Thymomas, neuroendocrine tumors, and thymic carcinomas are subtypes of thymic epithelial tumors, with thymomas being the most prevalent (75%\u201380%) and thymic carcinomas following at 15%\u201320%. Thymoma and thymic carcinoma exhibit distinct disease courses; thymomas grow slowly and are confined to the thymus, while thymic carcinomas demonstrate rapid growth and metastasis. Overall survival rates vary, with a 78% 5-year survival rate for thymoma and a 30% rate for thymic carcinoma. Thymic epithelial tumors may be linked to paraneoplastic autoimmune diseases, including myasthenia gravis, hypogammaglobulinemia, pure red cell aplasia, Cushing's syndrome, systemic lupus erythematosus, and polymyositis. Staging of thymic epithelial tumors can be done according to Masaoka-Koga and\/or TNM 8th staging systems. The treatment algorithm is primarily determined by resectability, with surgery (Extended Thymectomy) serving as the foundational treatment for early-stage patients (TNM stage I-IIIA, Masaoka-Koga stage I-III). Adjuvant radiotherapy or chemotherapy may be considered following surgery. In advanced or metastatic cases, chemotherapy is the first-line treatment, followed by surgery and radiotherapy for local control. Myasthenia gravis, an autoimmune disease presents with progressive muscle fatigue and diplopia. Positive antibodies (Anti-AChR, Anti-MuSK, LRP4) and electromyography aid in diagnosis, and approximately 10% of myasthenia gravis patients can also have thymoma. Treatment includes cholinesterase inhibitors and immunotherapy agents, with extended thymectomy serving as an effective surgical option for drug-resistant cases. Minimally invasive approaches (video-assisted thoracoscopic surgery or robot-assisted thoracoscopic surgery) have demonstrated comparable oncological outcomes to sternotomy, highlighting their effectiveness and reliability.<\/jats:p>","DOI":"10.3389\/fsurg.2024.1467789","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T06:14:26Z","timestamp":1731910466000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgical treatment of thymic epithelial tumor and myasthenia gravis"],"prefix":"10.3389","volume":"11","author":[{"given":"Gizem","family":"\u00d6z\u00e7\u0131b\u0131k I\u015f\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Turna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e31741","DOI":"10.1097\/MD.0000000000031741","article-title":"Prognostic value of tumor size in thymic epithelial tumors: a systematic review and meta-analysis","volume":"101","author":"Shao","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"631649","DOI":"10.3389\/fonc.2021.631649","article-title":"Predicting Masaoka-Koga clinical stage of thymic epithelial tumors using preoperative spectral computed tomography imaging","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cncr.34678","article-title":"Understanding the landscape of immunotherapy in thymic epithelial tumors","volume":"129","author":"Maniar","year":"2023","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-023-01772-4","article-title":"Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives","volume":"22","author":"Ao","year":"2023","journal-title":"Mol Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0227197","DOI":"10.1371\/journal.pone.0227197","article-title":"Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States","volume":"14","author":"Hsu","year":"2020","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/SLA.0b013e3181dd4ec4","article-title":"Thymic neuroendocrine tumors: a SEER database analysis of 160 patients","volume":"251","author":"Gaur","year":"2010","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/1759-7714.14847","article-title":"Chinese Expert consensus on the diagnosis and treatment of thymic epithelial tumors","volume":"14","author":"Xu","year":"2023","journal-title":"Thorac Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jtho.2022.02.001","article-title":"Trends in incidence and survival of patients with thymic epithelial tumor in a high-incidence Asian country: analysis of the Korean central cancer registry 1999 to 2017","volume":"17","author":"Shin","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.21037\/tlcr.2019.11.21","article-title":"The characteristics and prognostic role of thymic epithelial tumors with paraneoplastic autoimmune syndromes","volume":"8","author":"Hirai","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s002689900029","article-title":"Pulmonary and thymic carcinoid tumors","volume":"20","author":"Dusmet","year":"1996","journal-title":"World J Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2152\/jmi.55.17","article-title":"Optimal therapy for thymoma","volume":"55","author":"Kondo","year":"2008","journal-title":"J Med Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.jtho.2023.09.002","article-title":"The international association for the study of lung cancer thymic epithelial tumors staging project: proposal for a stage classification for the forthcoming (ninth) edition of the TNM classification of malignant tumors","volume":"18","author":"Ruffini","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/med-21-63","article-title":"Update on the TNM 8th edition-staging of thymic epithelial tumors, a pathologist\u2019s perspective","volume":"6","author":"Molina","year":"2022","journal-title":"Mediastinum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jtho.2023.08.024","article-title":"The international association for the study of lung cancer thymic epithelial tumor staging project: proposal for the T component for the forthcoming (ninth) edition of the TNM classification of malignant tumors","volume":"18","author":"Okumura","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11%3C2485::AID-CNCR2820481123%3E3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.3390\/cancers13215254","article-title":"Masaoka-Koga and TNM staging system in thymic epithelial tumors: prognostic comparison and the role of the number of involved structures","volume":"13","author":"Chiappetta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jtho.2022.10.016","article-title":"Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a systematic review","volume":"18","author":"Falkson","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.annonc.2021.01.003","article-title":"Lung and thymic carcinoids: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Baudin","year":"2021","journal-title":"Ann Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1615\/CritRevOncog.2017020577","article-title":"Precise diagnosis and treatment of thymic epithelial tumors based on molecular biomarkers","volume":"22","author":"Du","year":"2017","journal-title":"Crit Rev Oncog"},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11864-009-0083-7","article-title":"Treatment of advanced thymoma and thymic carcinoma","volume":"9","author":"Rajan","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.21037\/jtd.2019.08.38","article-title":"Surgical approach for thymic epithelial tumor","volume":"11","author":"Shintani","year":"2019","journal-title":"J Thorac Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/annonc\/11.suppl_3.245","article-title":"Treatment of thymoma and thymic carcinoma","volume":"11","author":"Giaccone","year":"2000","journal-title":"Ann Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/1759-7714.13181","article-title":"Optimal first-line treatment for advanced thymic carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/CCO.0000000000000355","article-title":"Systemic treatment for thymic malignancies","volume":"29","author":"Girard","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.21037\/jtd-2019-thym-12","article-title":"Immunotherapy for thymoma","volume":"12","author":"Jakopovic","year":"2020","journal-title":"J Thorac Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/JTO.0000000000000429","article-title":"Diffuse high intensity PD-L1 staining in thymic epithelial tumors","volume":"10","author":"Padda","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1158\/1078-0432.CCR-16-0434","article-title":"Prognostic value of programmed death ligand 1 and programmed death 1 expression in thymic carcinoma","volume":"22","author":"Yokoyama","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"E1141","DOI":"10.1503\/cmaj.180656","article-title":"Myasthenia gravis","volume":"190","author":"Bourque","year":"2018","journal-title":"CMAJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0011-5029(97)90033-X","article-title":"Myasthenia gravis","volume":"43","author":"Pourmand","year":"1997","journal-title":"Dis Mon"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3949\/ccjm.90a.22017","article-title":"Myasthenia gravis: frequently asked questions","volume":"90","author":"Morren","year":"2023","journal-title":"Cleve Clin J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/ITT.S377056","article-title":"Novel immunotherapies for myasthenia Gravis","volume":"12","author":"Nair","year":"2023","journal-title":"Immunotargets Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1749-6632.1966.tb45479.x","article-title":"Critical reappraisal of the use of edrophonium (tensilon) chloride tests in myasthenia gravis and significance of clinical classification","volume":"135","author":"Osserman","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4103\/0028-3886.55567","article-title":"Thymectomy in myasthenia gravis","volume":"57","author":"Murthy","year":"2009","journal-title":"Neurol India"},{"key":"B37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.thorsurg.2018.12.007","article-title":"Surgical decision making: thymoma and myasthenia Gravis","volume":"29","author":"Comacchio","year":"2019","journal-title":"Thorac Surg Clin"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1212757","DOI":"10.3389\/fimmu.2023.1212757","article-title":"Immunotherapies in MuSK-positive myasthenia Gravis; an IgG4 antibody-mediated disease","volume":"14","author":"Vakrakou","year":"2023","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.2147\/NDT.S296714","article-title":"Myasthenia Gravis and Lambert-eaton myasthenic syndrome: new developments in diagnosis and treatment","volume":"18","author":"Pascuzzi","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00415-023-11617-1","article-title":"Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis","volume":"270","author":"Vu","year":"2023","journal-title":"J Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1275533","DOI":"10.3389\/fneur.2023.1275533","article-title":"Rituximab treatment in myasthenia gravis","volume":"14","author":"Vesperinas-Castro","year":"2023","journal-title":"Front Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.2147\/NDT.S374694","article-title":"Ravulizumab in myasthenia Gravis: a review of the current evidence","volume":"19","author":"Vu","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mus.25597","article-title":"Rituximab treatment of myasthenia gravis: a systematic review","volume":"56","author":"Tandan","year":"2017","journal-title":"Muscle Nerve"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.4103\/1673-5374.363824","article-title":"Fcrn inhibitors: a novel option for the treatment of myasthenia gravis","volume":"18","author":"Zhu","year":"2023","journal-title":"Neural Regen Res"},{"key":"B46","first-page":"7","article-title":"Myasthenia Gravis","volume-title":"StatPearls","author":"Beloor Suresh","year":"2023"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/ene.15745","article-title":"Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: the MGSCIg study","volume":"30","author":"Pasnoor","year":"2023","journal-title":"Eur J Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13019-023-02283-5","article-title":"Preoperative respiratory muscle training combined with aerobic exercise improves respiratory vital capacity and daily life activity following surgical treatment for myasthenia gravis","volume":"18","author":"Chen","year":"2023","journal-title":"J Cardiothorac Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e37584","DOI":"10.7759\/cureus.37584","article-title":"Effect of thymectomy on outcomes of myasthenia Gravis patients: a case-control study at a tertiary care hospital","volume":"15","author":"Khawaja","year":"2023","journal-title":"Cureus"},{"key":"B50","first-page":"2","article-title":"Thymectomy","volume-title":"StatPearls","author":"Bennett","year":"2023"},{"key":"B51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12893-023-02228-8","article-title":"Robot versus video-assisted thoracoscopic thymectomy for large thymic epithelial tumors: a propensity-matched analysis","volume":"23","author":"Zhu","year":"2023","journal-title":"BMC Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2100543","DOI":"10.1002\/advs.202100543","article-title":"Recent advancements in regenerative approaches for Thymus rejuvenation","volume":"8","author":"Sharma","year":"2021","journal-title":"Adv Sci (Weinh"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1061264","DOI":"10.3389\/fonc.2023.1061264","article-title":"Risk factors for postoperative myasthenia gravis in patients with thymoma without myasthenia gravis: a systematic review and meta-analysis","volume":"13","author":"Tang","year":"2023","journal-title":"Front Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/intimm\/dxy081","article-title":"Thymus machinery for T-cell selection","volume":"31","author":"Kondo","year":"2019","journal-title":"Int Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.asjsur.2022.12.070","article-title":"Thymic carcinoma with myasthenia gravis: A case report","volume":"46","author":"Wang","year":"2023","journal-title":"Asian J Surg"},{"key":"B56","first-page":"2","article-title":"Anesthesia for patients with myasthenia Gravis","volume-title":"StatPearls","author":"Neuman","year":"2022"},{"key":"B57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12871-023-02296-6","article-title":"Propofol TCI or sevoflurane anesthesia without muscle relaxant for thoracoscopic thymectomy in myasthenia gravis patients: a prospective, observational study","volume":"23","author":"Hien","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia Gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s42466-023-00252-w","article-title":"The impact of thymectomy in subgroups of myasthenia gravis patients: a single center longitudinal observation","volume":"5","author":"Menghesha","year":"2023","journal-title":"Neurol Res Pract"},{"key":"B60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.nmd.2023.03.005","article-title":"Outcomes after robotic thymectomy in nonthymomatous versus thymomatous patients with acetylcholine-receptor-antibody-associated myasthenia gravis","volume":"33","author":"Marcuse","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.21037\/jtd-22-1589","article-title":"Outcomes after thymectomy in non-thymomatous myasthenia gravis","volume":"15","author":"Deboever","year":"2023","journal-title":"J Thorac Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/WCO.0000000000001189","article-title":"Thymectomy in myasthenia gravis","volume":"36","author":"Rath","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.xjtc.2022.08.017","article-title":"Subxiphoid-subcostal versus transthoracic thoracoscopic thymectomy: a safe and feasible approach","volume":"16","author":"Rao","year":"2022","journal-title":"JTCVS Tech"},{"key":"B64","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.thorsurg.2010.02.005","article-title":"Extended transsternal thymectomy","volume":"20","author":"Daniel","year":"2010","journal-title":"Thorac Surg Clin"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1048547","DOI":"10.3389\/fsurg.2022.1048547","article-title":"Robot-assisted thoracoscopic surgery vs. Sternotomy for thymectomy: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2023","journal-title":"Front Surg"},{"key":"B66","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/ejcts\/ezab224","article-title":"Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European society of thoracic surgeons thymic working group study","volume":"60","author":"Guerrera","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1073641","DOI":"10.3389\/fonc.2022.1073641","article-title":"The role of surgery in advanced thymic tumors: a retrospective cohort study","volume":"12","author":"Qi","year":"2023","journal-title":"Front Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/med-20-34","article-title":"The role of surgery in the management of locally advanced and metastatic thymoma: a narrative review","volume":"5","author":"Wagner","year":"2021","journal-title":"Mediastinum"},{"key":"B69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-0033-1345303","article-title":"Extended surgical resections of advanced thymoma masaoka stages III and IVa facilitate outcome","volume":"62","author":"Ried","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"B70","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/mus.27220","article-title":"Thymoma pathology and myasthenia gravis outcomes","volume":"63","author":"Menon","year":"2021","journal-title":"Muscle Nerve"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2024.1467789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T06:14:32Z","timestamp":1731910472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2024.1467789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":70,"alternative-id":["10.3389\/fsurg.2024.1467789"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2024.1467789","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"article-number":"1467789"}}